David R Bangsberg

Author PubWeight™ 433.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006 31.79
2 Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006 11.71
3 Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011 9.20
4 Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 2008 8.70
5 Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006 8.57
6 Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006 7.14
7 Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012 7.04
8 Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007 5.97
9 Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003 5.52
10 Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med 2006 4.86
11 Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004 4.58
12 Food insufficiency is associated with high-risk sexual behavior among women in Botswana and Swaziland. PLoS Med 2007 4.48
13 Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 2008 4.38
14 Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 2009 4.34
15 Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 2012 4.26
16 Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 2010 4.20
17 Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004 3.75
18 The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr 2009 3.67
19 Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002 3.53
20 Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007 3.46
21 What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr 2012 3.44
22 Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav 2009 3.39
23 Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis 2007 3.16
24 Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One 2008 3.13
25 Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 2010 3.08
26 Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc 2013 3.00
27 Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr 2009 2.99
28 Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med 2008 2.97
29 HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health 2004 2.96
30 Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 2009 2.86
31 Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation. AIDS 2010 2.70
32 Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting. AIDS 2012 2.63
33 A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006 2.61
34 Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda. AIDS Behav 2008 2.53
35 Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis 2007 2.51
36 Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med 2013 2.44
37 Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 2011 2.43
38 HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr 2014 2.43
39 The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007 2.39
40 Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis 2004 2.33
41 Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. Am J Clin Nutr 2011 2.32
42 The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr 2009 2.31
43 Doubts about DOT: antiretroviral therapy for resource-poor countries. AIDS 2003 2.28
44 Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med 2013 2.25
45 Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One 2010 2.24
46 Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011 2.21
47 Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr 2013 2.15
48 Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women. Am J Epidemiol 2011 2.12
49 BRIEF REPORT: the aging of the homeless population: fourteen-year trends in San Francisco. J Gen Intern Med 2006 2.03
50 Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007 2.00
51 Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS One 2012 1.99
52 Managing the demand for global health education. PLoS Med 2011 1.96
53 Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS 2009 1.95
54 A population-based study on alcohol and high-risk sexual behaviors in Botswana. PLoS Med 2006 1.95
55 Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis 2009 1.94
56 Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San Francisco. AIDS Behav 2009 1.91
57 Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med 2012 1.88
58 Revolving doors: imprisonment among the homeless and marginally housed population. Am J Public Health 2005 1.86
59 Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Med 2006 1.85
60 Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav 2010 1.83
61 HIV counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav 2006 1.83
62 Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One 2010 1.83
63 Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trials. J Acquir Immune Defic Syndr 2006 1.81
64 Global health training in US graduate psychiatric education. Acad Psychiatry 2014 1.78
65 The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Curr HIV/AIDS Rep 2006 1.77
66 Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. Am J Public Health 2008 1.77
67 Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health 2010 1.75
68 The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One 2009 1.72
69 Interactive "Video Doctor" counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One 2008 1.71
70 Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr 2010 1.68
71 A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry 2010 1.66
72 Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav 2011 1.66
73 Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One 2011 1.65
74 Scope of global health training in U.S. obstetrics and gynecology residency programs. Obstet Gynecol 2013 1.64
75 Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS 2003 1.63
76 Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS 2007 1.62
77 Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med 2002 1.58
78 Adherence without access to antiretroviral therapy in sub-Saharan Africa? AIDS 2006 1.57
79 The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. Soc Sci Med 2011 1.55
80 A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med 2011 1.53
81 Food insecurity and sexual risk in an HIV endemic community in Uganda. AIDS Behav 2011 1.52
82 Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure. AIDS 2012 1.52
83 Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One 2011 1.50
84 Reproductive decision-making and periconception practices among HIV-positive men and women attending HIV services in Durban, South Africa. AIDS Behav 2013 1.50
85 Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep 2011 1.50
86 Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis 2010 1.49
87 GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS 2013 1.46
88 Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004 1.46
89 Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed. J Acquir Immune Defic Syndr 2005 1.46
90 Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One 2011 1.43
91 Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS 2012 1.42
92 Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med 2004 1.41
93 Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr 2012 1.41
94 Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain 2011 1.40
95 Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One 2012 1.39
96 Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr 2013 1.39
97 Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav 2012 1.38
98 High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak 2012 1.36
99 Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda. PLoS One 2010 1.35
100 Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS 2016 1.34
101 Spending more to save more: interventions to promote adherence. Ann Intern Med 2010 1.34
102 Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS 2011 1.33
103 Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res 2011 1.33
104 Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav 2014 1.31
105 Food insecurity is associated with greater acute care utilization among HIV-infected homeless and marginally housed individuals in San Francisco. J Gen Intern Med 2012 1.31
106 Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS 2015 1.30
107 The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS 2016 1.30
108 Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS One 2013 1.29
109 Harnessing poverty alleviation to reduce the stigma of HIV in Sub-Saharan Africa. PLoS Med 2013 1.27
110 Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Trop Med Int Health 2014 1.26
111 Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda. AIDS 2014 1.25
112 Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes 2012 1.24
113 A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa. Am J Epidemiol 2012 1.24
114 Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. J Int AIDS Soc 2011 1.24
115 Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest Uganda. AIDS Behav 2007 1.22
116 The independent effect of drug resistance on T cell activation in HIV infection. AIDS 2006 1.22
117 How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav 2013 1.21
118 Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda. J Acquir Immune Defic Syndr 2012 1.20
119 How treatment partners help: social analysis of an African adherence support intervention. AIDS Behav 2012 1.19
120 HIV-specific IL-10-positive CD8+ T cells suppress cytolysis and IL-2 production by CD8+ T cells. J Immunol 2007 1.19
121 Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health 2012 1.18
122 Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study. J Acquir Immune Defic Syndr 2015 1.17
123 The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes. J Acquir Immune Defic Syndr 2008 1.16
124 Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One 2013 1.16
125 Lost opportunities to reduce periconception HIV transmission: safer conception counseling by South African providers addresses perinatal but not sexual HIV transmission. J Acquir Immune Defic Syndr 2014 1.15
126 Whoonga: potential recreational use of HIV antiretroviral medication in South Africa. AIDS Behav 2014 1.15
127 Internet use among Ugandan adolescents: implications for HIV intervention. PLoS Med 2006 1.15
128 Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS 2013 1.14
129 Examining theoretic models of adherence for validity in resource-limited settings. A heuristic approach. J Acquir Immune Defic Syndr 2006 1.14
130 MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav 2013 1.14
131 Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions. AIDS Behav 2008 1.14
132 Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS 2004 1.13
133 Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS 2012 1.13
134 Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS 2014 1.12
135 Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy. AIDS Res Hum Retroviruses 2007 1.10
136 Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS One 2012 1.10
137 Alcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western Uganda. BMC Public Health 2013 1.10
138 Brief report: Factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. J Gen Intern Med 2006 1.09
139 Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007 1.09
140 Self-Report of Alcohol Use Increases When Specimens for Alcohol Biomarkers Are Collected in Persons With HIV in Uganda. J Acquir Immune Defic Syndr 2012 1.09
141 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav 2008 1.08
142 Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr 2014 1.07
143 A conceptual framework for understanding HIV risk behavior in the context of supporting fertility goals among HIV-serodiscordant couples. Reprod Health Matters 2012 1.07
144 The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med 2014 1.07
145 A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy. J Acquir Immune Defic Syndr 2015 1.05
146 Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda. AIDS Behav 2013 1.05
147 Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda. J Int Assoc Physicians AIDS Care (Chic) 2007 1.05
148 Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons. AIDS 2011 1.05
149 Optimizing network connectivity for mobile health technologies in sub-Saharan Africa. PLoS One 2012 1.04
150 Food insecurity and risky sexual behaviors among homeless and marginally housed HIV-infected individuals in San Francisco. AIDS Behav 2013 1.04
151 A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers. PLoS One 2013 1.04
152 Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. J Acquir Immune Defic Syndr 2013 1.03
153 Health information seeking among Mbararan adolescents: results from the Uganda Media and You survey. Health Educ Res 2007 1.03
154 Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons. AIDS 2005 1.02
155 Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence. HIV Clin Trials 2004 1.02
156 HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS 2013 1.02
157 Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology 2013 1.01
158 Depression and drug use impact health status among marginally housed HIV-infected individuals. AIDS Patient Care STDS 2003 1.01
159 Food insecurity and HIV clinical outcomes in a longitudinal study of urban homeless and marginally housed HIV-infected individuals. AIDS 2013 1.00
160 The importance of social ties in sustaining medication adherence in resource-limited settings. J Gen Intern Med 2011 1.00
161 Gender-specific correlates of sex trade among homeless and marginally housed individuals in San Francisco. J Urban Health 2006 1.00
162 Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 2006 1.00
163 Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manage 2011 1.00
164 Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. J Acquir Immune Defic Syndr 2015 1.00
165 Social, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected men. PLoS One 2012 0.99
166 Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells. J Immunol 2008 0.98
167 An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr 2014 0.98
168 High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis. J Acquir Immune Defic Syndr 2014 0.97
169 Adolescent abstinence and unprotected sex in CyberSenga, an Internet-based HIV prevention program: randomized clinical trial of efficacy. PLoS One 2013 0.97
170 Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health 2010 0.97
171 The HIV epidemic among individuals with mental illness in the United States. Curr HIV/AIDS Rep 2004 0.97
172 Adherence to HIV care after pregnancy among women in sub-Saharan Africa: falling off the cliff of the treatment cascade. Curr HIV/AIDS Rep 2015 0.96
173 The HIV Epidemic Among Individuals with Mental Illness in the United States. Curr Infect Dis Rep 2004 0.96
174 Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS 2015 0.95
175 Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults. PLoS One 2008 0.95
176 The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav 2014 0.95
177 Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003. J Urban Health 2007 0.95
178 Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children. AIDS Behav 2008 0.95
179 South Africans with recent pregnancy rarely know partner's HIV serostatus: implications for serodiscordant couples interventions. BMC Public Health 2014 0.95
180 HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr 2016 0.94
181 The WHOMEN's scale (Women's HAART Optimism Monitoring and EvaluatioN Scale v.1) and the association with fertility intentions and sexual behaviours among HIV-positive women in Uganda. AIDS Behav 2009 0.94
182 The impact of chronic hepatitis C on health-related quality of life in homeless and marginally housed individuals with HIV. AIDS Behav 2007 0.94
183 Sexual relationship power and depression among HIV-infected women in Rural Uganda. PLoS One 2012 0.94
184 Computerized counseling reduces HIV-1 viral load and sexual transmission risk: findings from a randomized controlled trial. J Acquir Immune Defic Syndr 2014 0.94
185 High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology 2007 0.93
186 Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis. J Acquir Immune Defic Syndr 2009 0.93
187 Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda. AIDS Behav 2010 0.92
188 Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda. AIDS Res Hum Retroviruses 2014 0.92
189 Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav 2015 0.91
190 Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial. AIDS Behav 2013 0.91
191 Cash benefits are associated with lower risk behavior among the homeless and marginally housed in San Francisco. J Urban Health 2005 0.91
192 Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS 2014 0.91
193 Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 2014 0.90
194 Prevalence rates of sexual coercion victimization and perpetration among Uganda adolescents. AIDS Care 2012 0.90
195 Decreases in self-reported alcohol consumption following HIV counseling and testing at Mulago Hospital, Kampala, Uganda. BMC Infect Dis 2014 0.90
196 Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS 2015 0.90
197 Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One 2013 0.90
198 The analgesic and antiplasmodial activities and toxicology of Vernonia amygdalina. J Med Food 2008 0.90
199 Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco. AIDS Behav 2014 0.89
200 CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS 2014 0.89
201 HIV-specific TGF-beta-positive CD4+ T cells do not express regulatory surface markers and are regulated by CTLA-4. AIDS Res Hum Retroviruses 2010 0.88
202 Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. J Acquir Immune Defic Syndr 2014 0.88
203 Opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. JAMA Intern Med 2013 0.88
204 Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda. AIDS Res Hum Retroviruses 2011 0.88
205 Examining the applicability of the IMB model in predicting condom use among sexually active secondary school students in Mbarara, Uganda. AIDS Behav 2013 0.87
206 Influence of the US President's Emergency Plan for AIDS Relief (PEPfAR) on career choices and emigration of health-profession graduates from a Ugandan medical school: a cross-sectional study. BMJ Open 2013 0.87
207 Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa. AIDS Behav 2009 0.87
208 HIV seroconversion among the homeless and marginally housed in San Francisco: a ten-year study. J Acquir Immune Defic Syndr 2004 0.87
209 Smoking behaviors in a community-based cohort of HIV-infected indigent adults. AIDS Behav 2014 0.85
210 Hepatitis A seroprevalence and risk factors among homeless adults in San Francisco: should homelessness be included in the risk-based strategy for vaccination? Public Health Rep 2009 0.85
211 Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes? Pharmacogenet Genomics 2013 0.83
212 Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study. AIDS Behav 2015 0.83
213 Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya. AIDS Behav 2015 0.83
214 Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav 2012 0.83
215 TGF-beta and IL-10 production by HIV-specific CD8+ T cells is regulated by CTLA-4 signaling on CD4+ T cells. PLoS One 2009 0.82
216 Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. J Acquir Immune Defic Syndr 2015 0.82
217 Expanding provider-initiated HIV testing at STI clinics in China. AIDS Care 2012 0.81
218 No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav 2013 0.81
219 Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control 2004 0.81
220 Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial. PLoS One 2013 0.81
221 The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention. AIDS Behav 2014 0.81
222 Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards. PLoS Med 2013 0.81
223 Households with young children and use of freely distributed bednets in rural Madagascar. Int Health 2013 0.81
224 Know your audience: predictors of success for a patient-centered texting app to augment linkage to HIV care in rural Uganda. J Med Internet Res 2015 0.80
225 Socio-cultural and economic antecedents of adolescent sexual decision-making and HIV-risk in rural Uganda. AIDS Care 2012 0.80
226 The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) 2012 0.80
227 A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy. PLoS One 2011 0.80
228 Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS 2016 0.80
229 The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa. J Acquir Immune Defic Syndr 2015 0.79
230 Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral load. AIDS Res Hum Retroviruses 2013 0.79
231 Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS 2017 0.78
232 Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav 2015 0.78
233 The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav 2015 0.77
234 HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS 2016 0.76
235 The Achilles' heel of HIV treatment in resource-limited settings. J Acquir Immune Defic Syndr 2008 0.76
236 CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. Int J Epidemiol 2015 0.76
237 D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr 2016 0.75
238 Transforming health professionals' education. Lancet 2011 0.75
239 Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav 2014 0.75
240 Inkwari: an emerging high-risk place potentiating hiv spread among young adults in a hyper-endemic South African setting. Arch Sex Behav 2014 0.75
241 Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study. J Acquir Immune Defic Syndr 2015 0.75
242 In reply. Obstet Gynecol 2014 0.75
243 Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. J Acquir Immune Defic Syndr 2017 0.75
244 Free HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy. PLoS One 2013 0.75
245 How to Take HIV antiretroviral medications on time without a watch in rural Uganda. PLoS Med 2006 0.75
246 Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda. AIDS 2016 0.75
247 Prevalence and clinical impacts of HIV-1 intersubtype recombinants in uganda revealed by a near-full-genome population and deep sequencing approaches. AIDS 2017 0.75
248 Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapy. AIDS Read 2007 0.75
249 Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr 2017 0.75
250 Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital. Am J Infect Control 2002 0.75
251 Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa. J Acquir Immune Defic Syndr 2017 0.75
252 Should abacavir be a first-line alternative for adults with HIV in sub-Saharan Africa? J Acquir Immune Defic Syndr 2017 0.75